Foreign Investor In Human?

30 June 1996

- A foreign investor is reported to be behind the large turnover in shares of drugs producer Human on the Budapest Stock Exchange in the first week of June, according to MTI Econews. A total of 111,000 shares in Human changed hands during the week, with the firm's share price increasing from 1,550 forint ($10.17) per share to a 12-month high of 1,900 forint per share. The firm is known to have purchased 11,000 of its own shares, but commentators say that this would not explain the surge in the share price.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight